Abbott Laboratories
ABT
#53
Rank
$183.64 B
Marketcap
$105.33
Share price
-2.56%
Change (1 day)
-19.14%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

P/E ratio for Abbott Laboratories (ABT)

P/E ratio as of December 2022 (TTM): 22.4

According to Abbott Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.3911. At the end of 2021 the company had a P/E ratio of 35.2.

P/E ratio history for Abbott Laboratories from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202135.2-18.34%
202043.13.71%
201941.6-22.4%
201853.6-74.09%
2017207412.58%
201640.4167.34%
201515.1-49.14%
201429.728.56%
201323.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
24.6 9.71%๐Ÿ‡บ๐Ÿ‡ธ USA
9.19-58.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
9.59-57.18%๐Ÿ‡บ๐Ÿ‡ธ USA
20.5-8.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
31.4 40.23%๐Ÿ‡บ๐Ÿ‡ธ USA
111 395.52%๐Ÿ‡บ๐Ÿ‡ธ USA
14.3-36.13%๐Ÿ‡บ๐Ÿ‡ธ USA
26.0 16.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-163-828.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.47-80.03%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.